287840 IntoCell, Inc. KRX · South Korea

IntoCell (287840) news

IntoCell, Inc. is a public biotech or pharmaceutical company listed on KRX under the ticker 287840, recorded under South Korea. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest IntoCell news

We have not published a story on IntoCell yet. When there is news, it will appear here.

Questions about IntoCell

What is the ticker symbol of IntoCell?

IntoCell, Inc. trades under the ticker 287840 on KRX.

Where is IntoCell listed?

IntoCell, Inc. is listed on KRX.

Which country or territory is IntoCell listed under?

Our directory records IntoCell, Inc. under South Korea.

What does IntoCell do?

Our directory classifies IntoCell, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of IntoCell?

The ISIN recorded for IntoCell, Inc. is KR7287840003.

Does aibio.space cover IntoCell?

aibio.space lists IntoCell, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to IntoCell?

Companies in our directory listed in the same country and business area as IntoCell: SK bioscience Co.,Ltd., Quratis, ViGenCell, IMBiologics, HLB Genex, INNOGENE Co..

Investor discussion: IntoCell

Members talk about IntoCell (287840). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open KRX:287840 on TradingView.

Listing details

Company: IntoCell, Inc.
Ticker: 287840
Listing: KRX
Country or territory: South Korea
Business scope: Biotechnology
ISIN: KR7287840003
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction